3 completed, 1 terminated, 1 unknown. 5 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 3, Terminated 1, Unknown 1 |
| Phase 1 | 1 | Completed 1 |
Follow Head and Neck Neoplasm: new trials by email Literature Review of Head and Neck Neoplasm trials Research Report on Head and Neck Neoplasm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| IMRT Combined With Toripalimab in Unresectable Locally Recurrent Nasopharyngeal Carcinoma. Tolipalimab, Reirradiation - Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms | Phase 2 | Unknown | Sun Yat-sen University | 25 | 2019-05-01 | 2022-04-29 |
| Secured Access to Nivolumab for Adult Patients With Selected Rare Cancer Types Nivolumab - Carcinoma, Renal Cell, Head and Neck Neoplasm | Phase 2 | Completed | UNICANCER | 269 | 2017-06-16 | 2024-02-28 |
| HARE-40: HPV Anti-CD40 RNA vaccinE BNT113 - Human Papilloma Virus Related Carcinoma, Head and Neck Neoplasm | Phase 1 / Phase 2 | Completed | University of Southampton | 30 | 2017-04-11 | 2026-10-07 |
| Cetuximab as Induction Treatment in Head and Neck Squamous Cell Carcinoma (HNSCC) Cetuximab, Docetaxel, Cisplatin - Head and Neck Neoplasm | Phase 2 | Completed | Seoul National University Hospital | 92 | 2008-04-01 | 2013-12-04 |
| Phase 2 Study of Temozolomide in Pre-Selected Advanced Aerodigestive Tract Cancers (Study P04273AM2)(TERMINATED) Temozolomide - Colorectal Neoplasm, Head and Neck Neoplasm | Phase 2 | Terminated | Merck Sharp & Dohme LLC | 86 | 2007-01-26 | 2017-06-08 |
Head and Neck Neoplasms (5) · Penile Neoplasms (2) · Carcinoma, Non-Small-Cell Lung (1) · Carcinoma, Renal Cell (1) · Colorectal Neoplasms (1) · Esophageal Neoplasms (1) · Microsatellite Instability (1) · Nasopharyngeal Carcinoma (1) · Nasopharyngeal Diseases (1) · Nasopharyngeal Neoplasms (1) · Neoplasms, Unknown Primary (1) · Skin Neoplasms (1) · Uterine Cervical Neoplasms (1)
Neoplasms (5) · Neoplasms by Site (5) · Carcinoma (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Genital Diseases (2) · Genital Diseases, Male (2) · Genital Neoplasms, Male (2) · Male Urogenital Diseases (2) · Neoplasms by Histologic Type (2) · Neoplasms, Glandular and Epithelial (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Penile Diseases (2) · Urogenital Diseases (2)
Cetuximab (1) · Cisplatin (1) · Docetaxel (1) · Nivolumab (1) · Re-Irradiation (1) · Temozolomide (1)
Merck Sharp & Dohme LLC (1) · Seoul National University Hospital (1) · Sun Yat-sen University (1) · UNICANCER (1) · University of Southampton (1)
China (1) · France (1) · South Korea (1) · United Kingdom (1)
Christian Ottensmeier, Prof (1) · Dae Seog Heo, Prof. (1) · Ioannis Karydis, Dr (1) · Ming-Yuan Chen, MD,PhD (1)
PMID 23443801, PMID 26304911, PMID 34782428
2014 (1), 2016 (1)